[Occurrence of aminoglycoside transpherase genes in methicillin-resistant strains of Staphylococcus aureus]

Andrzej Młynarczyk1, Ksenia Szymanek-Majchrzak, Grazyna Młynarczyk

  • 1Katedra i Zakład Mikrobiologii Lekarskiej Warszawskiego Uniwersytetu Medycznego.

Medycyna Doswiadczalna I Mikrobiologia
|April 9, 2011
PubMed

Insights

This study investigated aminoglycoside resistance genes in Methicillin-Resistant Staphylococcus aureus (MRSA) from clinical samples. The presence of aacA-aphD, aadD, and aph(3")-IIIa genes correlated with gentamicin and tobramycin resistance.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Context:

  • Methicillin-Resistant Staphylococcus aureus (MRSA) poses a significant public health threat.
  • Aminoglycoside antibiotics are crucial for treating MRSA infections.
  • Understanding the genetic basis of aminoglycoside resistance in MRSA is essential for effective treatment strategies.

Purpose:

  • To identify the prevalence of three specific aminoglycoside resistance genes (aacA-aphD, aadD, aph(3")-IIIa) in clinical MRSA isolates.
  • To correlate the presence of these genes with the susceptibility of MRSA strains to a panel of aminoglycoside antibiotics.
  • To analyze the combinations and frequencies of these resistance genes within the MRSA population.

Summary:

  • Fifty clinical MRSA strains were analyzed using PCR for the presence of aacA-aphD, aadD, and aph(3")-IIIa genes.
  • aacA-aphD was detected in 34 strains, aadD in 27, and aph(3")-IIIa in 22 strains.
  • Multiple gene combinations were observed, with aacA-aphD and aadD being the most frequent co-occurring genes, and results were correlated with aminoglycoside antibiotic susceptibility.

Impact:

  • Provides data on the genetic landscape of aminoglycoside resistance in clinical MRSA.
  • Informs antibiotic stewardship and treatment guidelines for MRSA infections.
  • Highlights the importance of molecular methods for predicting antibiotic resistance in MRSA.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...